newsfilter
← Latest News
GlobeNewswire·

Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare Conference

PHILADELPHIA, June 05, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders,